0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Virus Filtration Market: Biologics Safety, Viral Clearance Technology, and Pharmaceutical Manufacturing ApplicationsThe Global Virus Filtration Market is a critical, high-growth sector within the bioprocessing industry, dedicated to ensuring the viral safety and purity of biological products. Driven by the exponential expansion of the biopharmaceutical pipeline—especially in advanced therapies like gene and cell therapies—and increasingly stringent global regulatory mandates, virus...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
A Specialty Niche: Biologics and Diagnostics Driving the EoE SegmentEosinophilic Esophagitis (EoE) is an increasingly recognized chronic, immune-mediated disease of the esophagus and a major cause of esophageal dysphagia, particularly in children and young adults. The market dedicated to EoE is a rapidly expanding specialty niche within the broader **Esophageal Dysphagia Market**, characterized by a strong focus on immunology and targeted pharmaceutical...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Advanced Cell Culture Technologies Propel the Biologics Manufacturing Industry ForwardThe global healthcare industry is undergoing a major transformation as biologics continue to redefine modern medicine. From monoclonal antibodies and vaccines to cell therapies and recombinant proteins, biologics manufacturing has become one of the most critical pillars of pharmaceutical innovation. Growing investments in biotechnology, rising chronic disease prevalence, and expanding demand...0 Комментарии 0 Поделились 203 Просмотры 0 предпросмотр
-
Bio simulation Market to Surge to USD 16.69 Billion by 2032 Riding a 16.23% CAGR on Rising Biologics R&D, AI-Enabled Modelling and Demand for Cost-Efficient Drug DevelopmentBiosimulation Market remarkable growth is being driven by a confluence of factors: rapid expansion in biologics and biosimilar development, the escalating burden of chronic diseases, rising demand for precision medicine, and regulatory momentum favoring in-silico simulation to streamline drug development, reduce costs, and accelerate time-to-market. Quick Insights...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Biologics Manufacturing Market: Innovation & Future OutlookThe pharmaceutical landscape is undergoing a seismic shift. If you looked at the top-selling drugs twenty years ago, you’d find mostly "small molecule" pills, aspirin, statins, and Ibuprofen. Today, the leaderboard is dominated by biologics. These complex, large-molecule therapies derived from living organisms are treating previously "untreatable" diseases, from chronic autoimmune...0 Комментарии 0 Поделились 448 Просмотры 0 предпросмотр
-
Biologics Market Research: Emerging Trends & Key Players | MRFRINDIA Biologics Market Technology Adoption and Innovations The INDIA Biologics Market Technology sector is advancing rapidly with the integration of single-use bioreactors, continuous manufacturing, and automation in biologics production. MRFR notes that these innovations reduce production costs, improve efficiency, and enhance product quality. Indian manufacturers are adopting these...0 Комментарии 0 Поделились 952 Просмотры 0 предпросмотр
-
Biologics Market Size Projected to Reach USD 1230.70 Billion by 2032“According to a new report published by Introspective Market Research, Biologics Market by Product Type, Application, and Manufacturing, The Global Biologics Market Size Was Valued at USD 509.3 Billion in 2023 and is Projected to Reach USD 1230.70 Billion by 2032, Growing at a CAGR of 10.3%.” Biologics, short for biological products, represent a transformative class of medicines...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Biologics Safety Testing Ensuring Product Sterility and Purity 2025`The Stringency of Safety Assurance for Advanced Therapies Biologics Safety Testing is a non-negotiable requirement for all Advanced Therapeutic Medicinal Products, especially those grown in complex biological media like HPL. Since HPL is a pooled human product, the risk assessment must be comprehensive, covering potential contaminants from the original donor material as well as those introduced...0 Комментарии 0 Поделились 807 Просмотры 0 предпросмотр
-
Biosimilars and Monoclonal Antibodies: Key Segments Driving China's Multi-Billion Dollar Biologics ExpansionMonoclonal antibodies (MAbs) and biosimilars represent the twin engines of growth within the rapidly expanding **China Biologics Market**, collectively driving its valuation into the multi-billion dollar range. MAbs, which target specific antigens and offer unparalleled precision in treatment, are indispensable for complex disease management, particularly in oncology and chronic inflammatory...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Cancer Biologics Market – Cancer Biologics Market Growth Drivers & Emerging Therapies"Executive Summary Cancer Biologics Market: Growth Trends and Share Breakdown CAGR Value The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. Cancer Biologics Market research report is a verified source of data and information that...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Cancer Biologics Market: Breakthrough Therapies Shaping the Future of Oncology"Executive Summary Cancer Biologics Market Opportunities by Size and Share CAGR Value The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. The leading Cancer Biologics Market report is sure to guide in one or the other way to accomplish one...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Biosimilars Market Trends 2026: Global Industry Insights & OpportunitiesGlobal Biosimilars Market Size, Share & Growth Forecast (2026–2034) The Global Biosimilars Market is projected to grow significantly from USD 22.7 billion in 2025 to USD 68.4 billion by 2033, expanding at a CAGR of 15.3% during the forecast period. Biosimilars, which are highly similar versions of approved biologic drugs, are gaining widespread adoption due to...0 Комментарии 0 Поделились 688 Просмотры 0 предпросмотр
-
Demand for Effective Wound Closure Solutions Fuels Market Growth to US$ 9.42 BillionWound Care Biologics include bioactive dressings, tissue-engineered skin substitutes, and growth factor therapies that promote wound repair. They are particularly valuable for patients with chronic wounds that require advanced therapeutic intervention. According to the Business Market Insights “The Wound Care Biologics Market size is expected to reach US$ 9.42 Billion by 2033 from US$...0 Комментарии 0 Поделились 114 Просмотры 0 предпросмотр
-
Experts Predict Surge in Biologics Market Trends and Innovations AheadAs the healthcare landscape continues to evolve, experts are turning their attention to the Biologics Market, anticipating significant trends that will shape its future. The market, currently valued at USD 374.57 billion, is projected to experience an impressive growth trajectory, potentially reaching USD 3,338.29 billion by 2035. This acceleration is largely attributed to increasing demand for...0 Комментарии 0 Поделились 130 Просмотры 0 предпросмотр
-
Global Antibody Discovery Market by 2030: Growth Drivers, Industry Trends, and Future OutlookThe global antibody discovery market is experiencing steady expansion, fueled by the increasing demand for biologics and targeted therapies across the healthcare sector. The market size is projected to grow from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030, registering a CAGR of 6.7% during 2022–2030. Antibody discovery is a critical phase in biologics development, involving the...0 Комментарии 0 Поделились 313 Просмотры 0 предпросмотр
-
Global Growth Dynamics of the Biologics MarketThe Biologics Market is expanding at a rapid pace due to rising investment in life sciences and the growing prevalence of autoimmune and infectious diseases. Biologics, including vaccines, cell therapies, and monoclonal antibodies, offer targeted solutions that traditional small-molecule drugs cannot provide. With increasing healthcare expenditure and patient demand for advanced therapies,...0 Комментарии 0 Поделились 558 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek